ProKidney Corp (NAS:PROK)
$ 2.38 -0.02 (-0.83%) Market Cap: 300.00 Mil Enterprise Value: -123.60 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 21/100

Q3 2023 ProKidney Corp Earnings Call Transcript

Nov 14, 2023 / 01:00PM GMT
Release Date Price: $1.52 (-5.00%)
Operator

Good morning, ladies and gentlemen. And welcome to the Prokidney corporate update conference call. (Operator Instructions) As a reminder, this call is being recorded. At this time, it is now my pleasure to introduce your host, Dr. Glenn Schulman, Senior Vice President of Investor Relations. Please go ahead, sir.

Glenn Schulman
Prokidney Corp. - SVP of IR

Thank you, Rob. And good morning, everyone. And welcome to Prokidney's corporate update conference call. Yesterday evening after the markets closed, we issued a press release that provided several corporate updates. And then this morning, released our third quarter 2023 financial results press release and 10Q filing. Please note a replay of today's call will be available on the investors section of our website, approximately one after -- one hour after its completion.

Joining us on the call this morning are Prokidney's Chairman of the Board, Pablo Legorreta; Prokidney's Co-founder and member of the Scientific Advisory Board, Dr. Tim Bertram; and Prokidney's new Chief Executive Officer, Dr. Bruce

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot